AMEND news in 2026
-
AMEND USA to Collaborate on Lived Experience MEN1 Study
AMEND USA to Collaborate on New MEN1 Study
Read more
-
Board Member Thomas Lehrich Attends 2026 INCA Delegate Conference
Thomas Lehrich attends 2026 INCA Conference in Sofia, Bulgaria as North American delegate amongst over 25 countries.
Find out more
-
AMEND USA Welcomes Genetic Counseling Student Alison Merket
AMEND USA Welcomes Alison Merket from UT Southwestern for Fall 2026.
Find out more
-
AMEND USA to Host Community Insight and Peer Support Meeting August 31st
Register and find out more about the upcoming Community Insight and Peer Support Meeting happening on August 31st!
Read more
-
AMEND USA President Featured by the Neuroendocrine Tumor Research Foundation
AMEND USA is proud to share a recent feature by the Neuroendocrine Tumor Research Foundation highlighting our President, John Metzcar.
Read More
-
Board Member Thomas Lehrich will represent AMEND USA as a delegate at the International Neuroendocrine Cancer Alliance (INCA) Conference, to be held on September 6 in Sofia, Bulgaria
AMEND USA announces Board Member Thomas Lehrich will represent AMEND USA as a delegate at the International Neuroendocrine Cancer Alliance (INCA) Conference, to be held on September 6 in Sofia, Bulgaria.
Read more
-
A Message from John Metzcar, AMEND USA President
A Message from John Metzcar, AMEND USA President
Read more
-
AMEND USA Recognizes Mental Health Awareness Month
Celebrating Mental Health Awareness Month
Read more
-
National Nursing Week
Celebrating National Nursing Week
Read more
-
AMEND USA Launches National Community Survey to Shape Future Programs and Services
AMEND USA announces the launch of its 2026 Community Survey, a key initiative designed to better understand the needs, priorities, and experiences of individuals connected to the Multiple Endocrine Neoplasia (MEN) community.
Read more about the survey